Skip to main content
JAMA Network logoLink to JAMA Network
. 2020 Dec 16;325(8):785–787. doi: 10.1001/jama.2020.24243

All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020

Jeremy Samuel Faust 1,, Harlan M Krumholz 2, Chengan Du 3, Katherine Dickerson Mayes 4, Zhenqiu Lin 3, Cleavon Gilman 5, Rochelle P Walensky 6
PMCID: PMC7745134  PMID: 33325994

Abstract

This study compares all-cause excess mortality and COVID-19–related mortality during the early pandemic period (March-July 2020) with unintentional drug overdoses, the usual leading cause of death in young adults, during the same period in 2018 among adults aged 25 to 44 years.


Coronavirus disease 2019 (COVID-19) has caused a marked increase in all-cause deaths in the US, mostly among older adults.1 Although the burden of COVID-19 among hospitalized younger adults has been described, fewer data focus on mortality in this demographic, owing to lower case-fatality rates.2

Excess mortality reflects the full burden of the pandemic that may go uncaptured due to uncoded COVID-19 and other pandemic-related deaths. Accordingly, we examined all-cause excess mortality and COVID-19–related mortality during the early pandemic period among adults aged 25 to 44 years. Because unintentional drug overdoses are the usual leading cause of death in this demographic, COVID-19 deaths were compared with unintentional opioid deaths.

Methods

To determine excess mortality (the gap between observed and expected deaths), projected monthly expected deaths for 2020 were calculated by applying autoregressive integrated moving averages to US population and mortality counts (2015-2019).3 We examined 2020 population and seasonal autoregressive integrated moving averages for each of the 10 US Department of Health and Human Services (HHS) regions, which comprise the entire US and are the smallest subdivisions for which 2020 age-stratified COVID-19 mortality data are currently available from the National Center for Health Statistics. Population covariates were used to calculate 95% CIs for expected deaths.

Observed all-cause mortality and COVID-19 mortality (coded as either “underlying cause” or “multiple cause” of death) for March 1, 2020, to July 31, 2020, were obtained from provisional National Center for Health Statistics data (released October 28, 2020).4 Unintentional opioid overdose death counts (International Statistical Classification of Diseases and Related Health Problems, Tenth Revision codes X41-X44, Y11-Y15, and T40.0-6) for the corresponding period of 2018 (the most recently available data) were assembled for each HHS region.3 Incident rates per 100 000 person-months with 95% CIs were calculated for COVID-19 and unintentional opioid deaths using SAS, version 9.4. Statistical significance was defined as a 95% CI that excluded the null value.

This study used publicly available data and was not subject to institutional review approval.

Results

From March 1, 2020, to July 31, 2020, a total of 76 088 all-cause deaths occurred among US adults aged 25 to 44 years, which was 11 899 more than the expected 64 189 deaths (incident rate ratio, 1.19 [95% CI, 1.14-1.23]; Table). Nationally, excess mortality occurred in every month of the study period and overall in every HHS region (Table and eTable in the Supplement). Among adults aged 25 to 44 years, 4535 COVID-19 deaths were recorded, accounting for 38% (95% CI, 32%-48%) of the measured excess mortality.

Table. Excess, Coronavirus Disease 2019 (COVID-19)–Related, and Unintentional Opioid Overdose Deaths.

HHS region March-July 2020 March-July 2018
Expected deaths, No. (95% CI) Observed deaths, No. Ratio of observed/expected deaths (95% CI) Excess deaths, No. (95% CI) COVID-19 deaths, No. COVID-19 death rates per 100 000 person-months (95% CI) Excess deaths attributed to COVID-19, % Unintentional opioid overdose deaths, No. Unintentional opioid overdose death rates per 100 000 person-months (95% CI)
US total 64 189 (61 822-66 556) 76 088 1.19 (1.14-1.23) 11 899 (9373 to 14 266) 4535 1.02 (0.99-1.06) 38 10 347 2.38 (2.33-2.43)
March 12 881 (11 952-13 855) 13 531 1.05 (0.98-1.13) 650 (−333 to 1579) 332 0.38 (0.34-0.42) 51 2119 2.44 (2.33-2.54)
April 12 602 (11 611-13 620) 15 106 1.20 (1.11-1.30) 2504 (1476 to 3495) 1539 1.74 (1.65-1.83) 61 1994 2.29 (2.19-2.40)
May 12 848 (11 786-13 895) 15 792 1.23 (1.14-1.34) 2944 (1883 to 4006) 848 0.96 (0.89-1.03) 29 2068 2.38 (2.28-2.48)
June 12 761 (11 671-13 851) 15 078 1.18 (1.09-1.29) 2317 (1190 to 3407) 604 0.68 (0.63-0.74) 26 2062 2.37 (2.27-2.48)
July 13 098 (11 897-14 234) 16 581 1.27 (1.16-1.39) 3483 (2258 to 4684) 1212 1.37 (1.29-1.45) 35 2104 2.42 (2.32-2.52)
Region 2 4128 (3879-4377) 6305 1.53 (1.44-1.63) 2177 (1928 to 2426) 1310 3.56 (3.37-3.76) 60 1229 3.23 (3.05-3.42)
March 825 (721-929) 1120 1.36 (1.21-1.55) 295 (191 to 399) 172 2.34 (2.00-2.71) 58 238 3.13 (2.74-3.55)
April 810 (702-918) 1867 2.30 (2.03-2.66) 1057 (949 to 1165) 842 11.44 (10.68-12.24) 80 218 2.87 (2.50-3.27)
May 826 (715-937) 1286 1.56 (1.37-1.80) 460 (349 to 571) 221 3.00 (2.62-3.42) 48 260 3.42 (3.02-3.86)
June 824 (709-938) 1033 1.25 (1.10-1.46) 209 (95 to 324) 56 0.76 (0.57-0.99) 27 250 3.29 (2.89-3.72)
July 843 (725-961) 999 1.18 (1.04-1.38) 156 (38 to 274) 19 0.26 (0.16-0.40) 12 263 3.46 (3.05-3.90)
Region 6 8504 (8127-8882) 10 408 1.22 (1.17-1.28) 1904 (1526 to 2281) 725 1.21 (1.12-1.30) 38 539 0.92 (0.85-1.00)
March 1711 (1546-1875) 1774 1.04 (0.95-1.15) 63 (−101 to 228) 31 0.26 (0.18-0.37) 49 101 0.86 (0.70-1.05)
April 1688 (1521-1854) 1932 1.14 (1.04-1.27) 244 (78 to 411) 118 0.98 (0.81-1.18) 48 105 0.90 (0.73-1.09)
May 1712 (1543-1880) 2072 1.21 (1.10-1.34) 360 (192 to 529) 74 0.62 (0.48-0.77) 21 124 1.06 (0.88-1.26)
June 1689 (1517-1860) 2132 1.26 (1.15-1.41) 443 (272 to 615) 122 1.01 (0.84-1.21) 28 107 0.91 (0.75-1.10)
July 1706 (1533-1880) 2498 1.46 (1.33-1.63) 792 (618 to 965) 380 3.16 (2.85-3.50) 48 102 0.87 (0.71-1.06)
Region 9 8351 (8054-8648) 10 094 1.21 (1.17-1.25) 1743 (1446 to 2040) 668 0.91 (0.84-0.99) 38 677 0.94 (0.87-1.01)
March 1643 (1515-1772) 1698 1.03 (0.96-1.12) 55 (−74 to 183) 28 0.19 (0.13-0.28) 51 141 0.98 (0.82-1.15)
April 1656 (1525-1787) 1764 1.07 (0.99-1.16) 108 (−23 to 239) 90 0.62 (0.49-0.76) 83 117 0.81 (0.67-0.97)
May 1660 (1528-1793) 2015 1.21 (1.12-1.32) 355 (222 to 487) 99 0.68 (0.55-0.82) 28 122 0.85 (0.70-1.01)
June 1667 (1532-1802) 2086 1.25 (1.16-1.36) 419 (284 to 554) 129 0.88 (0.74-1.05) 31 155 1.08 (0.91-1.26)
July 1725 (1588-1861) 2531 1.47 (1.36-1.59) 806 (670 to 943) 322 2.20 (1.97-2.46) 40 142 0.99 (0.83-1.16)

During surges in HHS Region 2 (New York, New Jersey), the incident rate for all-cause mortality was 2.30 (95% CI, 2.03-2.66) and 80% of deaths were related to COVID-19; during surges in HHS Region 6 (Arkansas, Louisiana, New Mexico, Oklahoma, Texas), the incident rate was 1.46 (95% CI, 1.33-1.63) and 48% were related to COVID-19; and during surges in HHS Region 9 (Arizona, California, Hawaii, Nevada), the incident rate was 1.47 (95% CI, 1.36-1.59) and 40% were attributed to COVID-19.

In contrast, from March through July 2018, a total of 10 347 unintentional opioid deaths occurred among US adults aged 25 to 44 years. Deaths due to COVID-19 exceeded 2018 unintentional opioid deaths during 1 month in 2020 in HHS Region 2 (April), HHS Region 6 (July), and HHS Region 9 (July) and either exceeded (HHS Region 6) or were similar to (HHS Regions 2 and 9) unintentional opioid deaths during the entire study period (Table).

Discussion

The COVID-19 pandemic was associated with increases in all-cause mortality among US adults aged 25 to 44 years from March through July 2020. In 3 HHS regions, COVID-19 deaths were similar to or exceeded unintentional opioid overdoses that occurred during several corresponding months of 2018.

Only 38% of all-cause excess deaths in adults aged 25 to 44 years recorded during the pandemic were attributed directly to COVID-19. Although the remaining excess deaths are unexplained, inadequate testing in this otherwise healthy demographic likely contributed. These results suggest that COVID-19–related mortality may have been underdetected in this population.

This study has limitations. The provisional data used represent lower-bound estimates due to reporting lags, necessitating future updates. Additionally, although COVID-19 deaths exceeded unintentional opioid deaths in 2018 in some areas, it is possible that simultaneous increases in opioid deaths may have occurred during the pandemic period, making it less clear which of these 2 diseases represents the current leading cause of death among younger adults in areas experiencing COVID-19 surges.

Section Editor: Jody W. Zylke, MD, Deputy Editor.

Supplement.

eTable. Excess, Coronavirus Disease 2019 (COVID-19)–Related, and Unintentional Opioid Overdose Deaths in Select HHS Regions

References

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement.

eTable. Excess, Coronavirus Disease 2019 (COVID-19)–Related, and Unintentional Opioid Overdose Deaths in Select HHS Regions


Articles from JAMA are provided here courtesy of American Medical Association

RESOURCES